PRA Health Sciences, Inc. Net Income
PRA Health Sciences, Inc. reported Net Income of $56.94 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-29.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2021-04-29
- PRA Health Sciences, Inc. net income (loss) attributable to parent for the quarter ending 2021-03-31 was $56.94M, a 40.04% increase year-over-year.
- PRA Health Sciences, Inc. net income (loss) attributable to parent for the quarter ending 2020-12-31 was $51.26M, a 31.48% decline year-over-year.
- PRA Health Sciences, Inc. net income (loss) attributable to parent for the quarter ending 2020-09-30 was $91.25M, a 9.93% increase year-over-year.
- PRA Health Sciences, Inc. net income (loss) attributable to parent for the quarter ending 2020-06-30 was $13.87M, a 66.27% decline year-over-year.
- PRA Health Sciences, Inc. net income (loss) attributable to parent for fiscal 2020 was $197.04M, a 18.92% decline from fiscal 2019.
- PRA Health Sciences, Inc. net income (loss) attributable to parent for fiscal 2019 was $243.02M, a 57.90% increase from fiscal 2018.
- PRA Health Sciences, Inc. net income (loss) attributable to parent for fiscal 2018 was $153.91M, a 77.05% increase from fiscal 2017.
- PRA Health Sciences, Inc. net income (loss) attributable to parent for fiscal 2017 was $86.93M, a 27.51% increase from fiscal 2016.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2021-03-31 | $56.94M 10-Q · filed 2021-04-29 | $108.20M derived: sum of 2 quarters · filed 2021-04-29 | $199.45M derived: sum of 3 quarters · filed 2021-04-29 | $213.32M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | $51.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $142.51M derived: sum of 2 quarters · filed 2021-02-24 | $156.38M derived: sum of 3 quarters · filed 2021-02-24 | $197.04M 10-K · filed 2021-02-24 |
| 2020-09-30 | $91.25M 10-Q · filed 2020-11-05 | $105.13M derived: sum of 2 quarters · filed 2020-11-05 | $145.79M 10-Q · filed 2020-11-05 | $220.59M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-06-30 | $13.87M 10-Q · filed 2020-08-07 | $54.53M 10-Q · filed 2020-08-07 | $129.34M derived: sum of 3 quarters · filed 2021-04-29 | $212.34M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-03-31 | $40.66M 10-Q · filed 2021-04-29 | $115.46M derived: sum of 2 quarters · filed 2021-04-29 | $198.47M derived: sum of 3 quarters · filed 2021-04-29 | $239.60M derived: sum of 4 quarters · filed 2021-04-29 |
| 2019-12-31 | $74.80M 10-K · filed 2021-02-24 | $157.81M derived: sum of 2 quarters · filed 2021-02-24 | $198.94M derived: sum of 3 quarters · filed 2021-02-24 | $243.02M 10-K · filed 2021-02-24 |
| 2019-09-30 | $83.01M 10-K · filed 2021-02-24 | $124.14M derived: sum of 2 quarters · filed 2021-02-24 | $168.22M 10-Q · filed 2020-11-05 | $239.67M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $41.13M 10-K · filed 2021-02-24 | $85.21M 10-Q · filed 2020-08-07 | $156.66M derived: sum of 3 quarters · filed 2021-02-24 | $158.16M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $44.08M 10-K · filed 2021-02-24 | $115.54M derived: sum of 2 quarters · filed 2021-02-24 | $117.03M derived: sum of 3 quarters · filed 2021-02-24 | $159.01M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $71.45M 10-K · filed 2020-02-21 | $72.95M derived: sum of 2 quarters · filed 2020-02-21 | $114.92M derived: sum of 3 quarters · filed 2020-02-21 | $153.91M 10-K · filed 2021-02-24 |
| 2018-09-30 | $1.50M 10-K · filed 2020-02-21 | $43.47M derived: sum of 2 quarters · filed 2020-02-21 | $82.45M 10-Q · filed 2019-10-31 | $66.41M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $41.98M 10-K · filed 2020-02-21 | $80.96M 10-Q · filed 2019-08-01 | $64.91M derived: sum of 3 quarters · filed 2020-02-21 | $113.11M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $38.98M 10-K · filed 2020-02-21 | $22.93M derived: sum of 2 quarters · filed 2020-02-21 | $71.14M derived: sum of 3 quarters · filed 2020-02-21 | $100.68M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | -$16.05M 10-K · filed 2019-02-28 | $32.16M derived: sum of 2 quarters · filed 2019-02-28 | $61.70M derived: sum of 3 quarters · filed 2019-02-28 | $86.93M 10-K · filed 2020-02-21 |
| 2017-09-30 | $48.20M 10-K · filed 2019-02-28 | $77.75M derived: sum of 2 quarters · filed 2019-02-28 | $102.97M 10-Q · filed 2018-11-06 | $117.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $29.55M 10-K · filed 2019-02-28 | $54.77M 10-Q · filed 2018-08-02 | $68.80M derived: sum of 3 quarters · filed 2019-02-28 | $100.24M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $25.22M 10-K · filed 2019-02-28 | $39.25M derived: sum of 2 quarters · filed 2019-02-28 | $70.70M derived: sum of 3 quarters · filed 2019-02-28 | $109.37M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $14.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $45.47M derived: sum of 2 quarters · filed 2019-02-28 | $84.14M derived: sum of 3 quarters · filed 2019-02-28 | $68.17M 10-K · filed 2019-02-28 |
| 2016-09-30 | $31.45M 10-Q · filed 2017-10-26 | $70.12M derived: sum of 2 quarters · filed 2017-10-26 | $54.15M 10-Q · filed 2017-10-26 | |
| 2016-06-30 | $38.67M 10-Q · filed 2017-08-08 | $22.70M 10-Q · filed 2017-08-08 | ||
| 2015-12-31 | $81.77M 10-K · filed 2018-02-22 |